Elanco Animal Health (ELAN) EBT Margin (2017 - 2026)
Elanco Animal Health (ELAN) posted EBT Margin of 6.35% for Q1 2026, up 128.03% sequentially from 22.64% in Q4 2025, and up 132.0% YoY from 2.74% in Q1 2025.
Elanco Animal Health (ELAN) EBT Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported EBT Margin for 10 years, with the latest figure at 6.35% in Q1 2026.
- Quarterly EBT Margin rose 132.0% year-over-year to 6.35% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.03% (down 1613.0% YoY) and the FY2025 annual result came in at 4.75%, down 1574.0% from the prior year.
- EBT Margin improved to 6.35% in Q1 2026 per ELAN's latest filing, from 22.64% in the prior quarter.
- Over five years, EBT Margin peaked at 54.27% in Q3 2024 and troughed at 102.72% in Q3 2023.
- A 5-year average of 5.2% and a median of 2.7% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 9843 bps in 2023, then jumped 15699 bps in 2024.
- Over 5 years, EBT Margin stood at 9.04% in 2022, then sank by 36 bps to 12.27% in 2023, then surged by 59 bps to 5.0% in 2024, then slumped by 353 bps to 22.64% in 2025, then soared by 128 bps to 6.35% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 6.35%, 22.64%, and 4.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.09% |
| Mar 31, 2026 | 6.35% |
| Dec 31, 2025 | -22.64% |
| Sep 30, 2025 | -4.40% |
| Jun 30, 2025 | 2.01% |
| Mar 31, 2025 | 5.03% |
| Dec 31, 2024 | -5.00% |
| Sep 30, 2024 | 54.27% |
| Jun 30, 2024 | -2.70% |
| Mar 31, 2024 | 1.00% |
| Dec 31, 2023 | -12.27% |
| Sep 30, 2023 | -102.72% |
| Jun 30, 2023 | -7.47% |
| Mar 31, 2023 | 8.59% |
| Dec 31, 2022 | -9.04% |
| Sep 30, 2022 | -4.29% |
| Jun 30, 2022 | -1.19% |
| Mar 31, 2022 | 6.12% |
| Dec 31, 2021 | -10.79% |
| Sep 30, 2021 | -11.49% |